| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a203d85ee01909eaf728dc16f0f6cb |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-02 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C255-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C49-327
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C45-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C49-293
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C45-004 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C49-293
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C255-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C49-327
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C45-63 |
| filingDate |
2005-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4909d987f002df8a5e0816ecbba23e02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6865f54f7deff5b7a6d4d275688ac504
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e49f8cdb8ef836f45fc2436e573f017
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1e97cf734b6e09c78c4979175133a9a |
| publicationDate |
2005-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
NO-20051833-L |
| titleOfInvention |
4- (3,5-dicyanophenoxy) pyrazole derivatives for use as transcriptase modulators in the treatment of IA HIV. |
| abstract |
Pyrazole derivatives of formula (I) and pharmaceutically acceptable salts, solvates or derivatives thereof are disclosed. Further described are the use of the compounds in medicine, preparations containing compounds, processes for the preparation of these compounds, as well as intermediates for use in these processes. The described compounds bind to the enzyme reverse transcriptase and are modulators and in particular inhibitors thereof. Reverse transcriptase is implicated in the infectious life cycle of the human immunodeficiency virus (HIV). Compounds that interfere with the function of this enzyme have shown utility in the treatment of conditions caused by HIV and genetically related retroviruses such as acquired immunodeficiency syndrome (AIDS). |
| priorityDate |
2002-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |